Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
ANZ Banking Group: I'm Taking The Profit

2018-07-04 seekingalpha
Interest rates were left unchanged again this week, continuing a streak started over twenty meetings ago.
RBA

1
Ritchie Bros. Auctioneers Incorporated (RBA) Sees Hammer Chart Pattern: Time to Buy?

2018-05-14 zacks
Ritchie Bros. Auctioneers Incorporated (RBA - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because RBA recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
RBA ISRG

1
Ritchie Bros. Auctioneers Inc. 2018 Q1 - Results - Earnings Call Slides

2018-05-11 seekingalpha
The following slide deck was published by Ritchie Bros. Auctioneers Inc. in conjunction with their 2018 Q1 earnings call.
RBA

1
RBA / Ritchie Bros. Auctioneers Inc. FORM 10-Q (Quarterly Report)

2018-05-10 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
RBA

7
5 Great Business Services Stocks to Buy Ahead of Q1 Earnings

2018-05-03 zacks
As markets growth increasingly volatile, fueled primarily by inflationary fears, it is easy to forget that the economy remains on a firm footing. Fresh evidence of this fact was provided by the ADP report for April which revealed that job additions had come in above 200,000 for the six straight month. Incidentally, professional and business services contributed nearly half of all the job additions experienced during April.
LNT RBA TRI BAH BKI

404
7 Best Platform Stocks to Buy Now | InvestorPlace

2018-04-05 investorplace
What are platform stocks? Which are the best platform stocks to buy and how can they make you rich?
RDFN BABA RBA ZG AMZN Z AAPL AXP MSFT

14
Why You Shouldn't Bet Against Ritchie Bros. Auctioneers (RBA) Stock

2018-04-02 zacks
One stock that might be an intriguing choice for investors right now is Ritchie Bros. Auctioneers Incorporated (RBA - Free Report) . This is because this security in the Auction and Valuation Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board.
LMT RBA TCRX AKG ENR TCRD TCRZ AKG TSLF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

22h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

23h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to RBA / Ritchie Bros. Auctioneers Inc. on message board site Silicon Investor.

Ritchie Bros. (RBA) UI.V - Urbanimmersive Technologies
HERBALIFE Ariba Technologies (Nasdaq-ARBA)
DROOY Durban Deep- Best S. African Mine New Urbanism
Hansen Natural Corp - Vitamin/Herbal Beverage Co Redback Networks, Inc. (RBAK)
Garbage Internet Stocks: Short the hype! Marimba, Inc. (MRBA)
CUSIP: 767744105